Exelixis
EXEL
#1694
Rang
€10.25 Md
Capitalisation boursière
38,10 €
Prix de l'action
-0.02%
Changement (1 jour)
11.91%
Changement (1 an)

Exelixis (EXEL) - Dette totale

Dette totale au bilan au Septembre 2025 : 0.15 Milliard d'euros

Selon les derniers rapports financiers d'Exelixis, la dette totale de l'entreprise est de 0.15 Milliard d'euros. La dette totale d'une entreprise est la somme de toutes les dettes courantes et non courantes.

Exelixis - Dette totale au bilan (de 2000 à 2025)

Dette totale par année

Année Dette totale Changement
2024-12-31€0.18 Md6.72%
2023-12-31€0.17 Md-3.08%
2022-12-31€0.17 Md291.59%
2021-12-31€45.27 M13.44%
2020-12-31€39.9 M-6.88%
2019-12-31€42.85 M228.7%
2018-12-31€13.03 M4.73%
2017-12-31€12.44 M-93.08%
2016-12-31€0.17 Md-52.96%
2015-12-31€0.38 Md30.23%
2014-12-31€0.29 Md16.73%
2013-12-31€0.25 Md-0.94%
2012-12-31€0.25 Md81.59%
2011-12-31€0.13 Md-10.81%
2010-12-31€0.15 Md182.02%
2009-12-31€55.57 M-33.98%
2008-12-31€84.17 M1.15%
2007-12-31€83.22 M-9.73%
2006-12-31€92.19 M-26.63%
2005-12-31€0.12 Md15.67%
2004-12-31€0.10 Md23.12%
2003-12-31€88.23 M24.75%
2002-12-31€70.72 M27.62%
2001-12-31€55.41 M249.21%
2000-12-31€15.86 M20.07%
1999-12-31€13.21 M

Dette totale pour des entreprises similaires ou concurrentes

Entreprise Dette totale/th> Dette totale différencediff. Pays
GlaxoSmithKline
GSK
€20.49 Md 13,422.38%🇬🇧 UK
Sanofi
SNY
€21.92 Md 14,368.36%🇫🇷 France
Merck
MRK
€35.53 Md 23,346.27%🇺🇸 USA
Bristol-Myers Squibb
BMY
€43.83 Md 28,824.48%🇺🇸 USA
Amgen
AMGN
€46.88 Md 30,833.96%🇺🇸 USA
Johnson & Johnson
JNJ
€39.33 Md 25,851.62%🇺🇸 USA
Pfizer
PFE
€52.26 Md 34,382.02%🇺🇸 USA
Curis
CRIS
€1.69 M-98.88%🇺🇸 USA
AVEO Oncology
AVEO
€33.22 M-78.08%🇺🇸 USA